BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37075624)

  • 1. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.
    Zhou D; Xu Z; Huang Y; Wang H; Zhu X; Zhang W; Song W; Gao T; Liu T; Wang M; Shi L; Zhang N; Xiong B
    Eur J Med Chem; 2023 Jun; 254():115369. PubMed ID: 37075624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
    Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
    FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines.
    Xu Z; Wang H; Meng Q; Ding Y; Zhu M; Zhou H; Zhang N; Shi L
    Biochem Pharmacol; 2023 Sep; 215():115746. PubMed ID: 37579857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of [1,2,3]triazolo[4,5-
    Liu Z; Zhao T; Li Z; Sun K; Fu Y; Cheng T; Guo J; Yu B; Shi X; Liu H
    Acta Pharm Sin B; 2020 Aug; 10(8):1476-1491. PubMed ID: 32963944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
    Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
    ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1.
    Liu Z; Chen M; Xu X; Zhang L; Pan Y; Chen D
    Acta Biochim Pol; 2021 Jun; 68(4):633-639. PubMed ID: 34106567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
    Ruiz EJ; Pinto-Fernandez A; Turnbull AP; Lan L; Charlton TM; Scott HC; Damianou A; Vere G; Riising EM; Da Costa C; Krajewski WW; Guerin D; Kearns JD; Ioannidis S; Katz M; McKinnon C; O'Connell J; Moncaut N; Rosewell I; Nye E; Jones N; Heride C; Gersch M; Wu M; Dinsmore CJ; Hammonds TR; Kim S; Komander D; Urbe S; Clague MJ; Kessler BM; Behrens A
    Elife; 2021 Oct; 10():. PubMed ID: 34636321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.
    Wang Z; Song Q; Xue J; Zhao Y; Qin S
    Exp Biol Med (Maywood); 2016 Feb; 241(3):255-64. PubMed ID: 26209720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity.
    Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X
    ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
    Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer.
    Maier CR; Hartmann O; Prieto-Garcia C; Al-Shami KM; Schlicker L; Vogel FCE; Haid S; Klann K; Buck V; Münch C; Schmitz W; Einig E; Krenz B; Calzado MA; Eilers M; Popov N; Rosenfeldt MT; Diefenbacher ME; Schulze A
    Cell Death Differ; 2023 Jul; 30(7):1710-1725. PubMed ID: 37202505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural optimization on a virtual screening hit of smoothened receptor.
    Song S; Jiang J; Zhao L; Wang Q; Lu W; Zheng C; Zhang J; Ma H; Tian S; Zheng J; Luo L; Li Y; Yang ZJ; Zhang X
    Eur J Med Chem; 2019 Jun; 172():1-15. PubMed ID: 30939349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
    Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
    J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression.
    Tian Y; Liu K; Liu R; Qiu Z; Xu Y; Wei W; Xu X; Wang J; Ding H; Li Z; Bian J
    J Med Chem; 2022 Jul; 65(13):8914-8932. PubMed ID: 35786929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway.
    Weili Z; Zhikun L; Jianmin W; Qingbao T
    J Cell Biochem; 2019 Jan; 120(1):201-212. PubMed ID: 30206969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational approach to target USP28 for regulating Myc.
    Chakravorty D; Ghosh A; Saha S
    Comput Biol Chem; 2020 Apr; 85():107208. PubMed ID: 32028107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.
    Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Bozkurt S; Pahor N; Fuss C; Schirbel A; Schülein-Völk C; Buchberger A; Calzado Canale MA; Rosenfeldt M; Dikic I; Münch C; Diefenbacher ME
    Mol Oncol; 2022 Sep; 16(17):3082-3106. PubMed ID: 35364627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-specific protease USP28 is required for MYC stability.
    Popov N; Wanzel M; Madiredjo M; Zhang D; Beijersbergen R; Bernards R; Moll R; Elledge SJ; Eilers M
    Nat Cell Biol; 2007 Jul; 9(7):765-74. PubMed ID: 17558397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and preclinical development of vismodegib.
    Gould SE; Low JA; Marsters JC; Robarge K; Rubin LL; de Sauvage FJ; Sutherlin DP; Wong H; Yauch RL
    Expert Opin Drug Discov; 2014 Aug; 9(8):969-84. PubMed ID: 24857041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity.
    Sinha N; Chowdhury S; Sarkar RR
    Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.